Form 4 for IRWD IRONWOOD PHARMACEUTICALS INC
Accepted 2025-11-19 00:00:00 ET · period of report 2025-11-17 · accession 0001193125-25-288086 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-11-19 | 2025-11-17 | IRWD | Gaskins Tammi L | Chief Commercial Off | S - Sale | $3.32 | -6,016 | 235.3K | -2% | -$20.0K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Class A Common Stock | 2025-11-17 | S | D | 6,016 | $3.32 | 235,264 | D | — | — |